Cytosorbents Non Current Assets Total vs Net Debt Analysis
CTSO Stock | USD 0.88 0.06 7.32% |
Cytosorbents Crp financial indicator trend analysis is way more than just evaluating Cytosorbents Crp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cytosorbents Crp is a good investment. Please check the relationship between Cytosorbents Crp Non Current Assets Total and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
Non Current Assets Total vs Net Debt
Non Current Assets Total vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cytosorbents Crp Non Current Assets Total account and Net Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cytosorbents Crp's Non Current Assets Total and Net Debt is -0.07. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Net Debt in the same time period over historical financial statements of Cytosorbents Crp, assuming nothing else is changed. The correlation between historical values of Cytosorbents Crp's Non Current Assets Total and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Cytosorbents Crp are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Current Assets Total i.e., Cytosorbents Crp's Non Current Assets Total and Net Debt go up and down completely randomly.
Correlation Coefficient | -0.07 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Cytosorbents Crp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cytosorbents Crp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.At this time, Cytosorbents Crp's Selling General Administrative is very stable compared to the past year. As of the 5th of May 2024, Issuance Of Capital Stock is likely to grow to about 17.5 M, while Tax Provision is likely to drop (854.4 K).
2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 62.9M | 60.9M | 66.9M | 70.2M | Total Revenue | 40.1M | 29.4M | 36.3M | 38.2M |
Cytosorbents Crp fundamental ratios Correlations
Click cells to compare fundamentals
Cytosorbents Crp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cytosorbents Crp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 27.4M | 90.0M | 89.5M | 63.2M | 53.3M | 55.9M | |
Short Long Term Debt Total | 16.1M | 1.0M | 13.8M | 18.3M | 18.3M | 19.2M | |
Total Current Liabilities | 9.9M | 10.2M | 13.7M | 9.7M | 14.5M | 15.3M | |
Net Debt | 3.9M | (70.4M) | (38.3M) | (3.9M) | 4.2M | 4.4M | |
Retained Earnings | (188.8M) | (196.6M) | (221.2M) | (254.0M) | (282.5M) | (268.4M) | |
Cash | 12.2M | 71.4M | 52.1M | 22.1M | 14.1M | 13.2M | |
Common Stock Total Equity | 32.6K | 43.2K | 43.5K | 43.6K | 39.3K | 51.6K | |
Common Stock Shares Outstanding | 32.3M | 38.8M | 43.4M | 43.6M | 44.7M | 46.9M | |
Liabilities And Stockholders Equity | 27.4M | 90.0M | 89.5M | 63.2M | 53.3M | 55.9M | |
Total Liab | 24.0M | 10.7M | 26.9M | 27.9M | 30.0M | 31.5M | |
Property Plant And Equipment Gross | 3.0M | 3.1M | 18.6M | 23.3M | 25.2M | 26.4M | |
Total Current Assets | 20.9M | 82.5M | 64.3M | 33.8M | 25.7M | 17.6M | |
Accumulated Other Comprehensive Income | 526.0K | (1.7M) | 525.6K | 2.3M | 529.3K | 555.8K | |
Other Current Liab | 5.6M | 6.8M | 8.2M | 6.3M | 6.5M | 6.8M | |
Total Stockholder Equity | 3.4M | 79.2M | 62.6M | 35.4M | 23.3M | 12.9M | |
Property Plant And Equipment Net | 3.0M | 3.1M | 18.6M | 23.3M | 22.1M | 23.2M | |
Non Current Assets Total | 6.5M | 7.5M | 25.2M | 29.5M | 27.6M | 28.9M | |
Cash And Short Term Investments | 12.2M | 71.4M | 52.1M | 22.1M | 14.1M | 14.1M | |
Non Current Liabilities Total | 14.0M | 582K | 13.3M | 18.1M | 15.4M | 16.2M | |
Other Stockholder Equity | 191.6M | 277.5M | 283.2M | 287.0M | 305.2M | 160.4M | |
Common Stock | 32.6K | 43.2K | 43.5K | 43.6K | 54.2K | 53.5K | |
Accounts Payable | 2.0M | 1.8M | 2.8M | 1.7M | 3.8M | 4.0M | |
Non Currrent Assets Other | 3.5M | 4.3M | 1.9M | 1.7M | (3.7M) | (3.5M) | |
Other Current Assets | 2.1M | 3.2M | 2.9M | 2.5M | 1.8M | 1.1M | |
Good Will | 1.8M | 2.6M | 3.4M | 4.2M | 4.9M | 5.1M | |
Intangible Assets | 3.4M | 4.2M | 4.7M | 4.4M | 3.9M | 4.1M | |
Other Assets | 123.5K | 5.4M | 6.6M | 1.7M | 2.0M | 1.1M | |
Property Plant Equipment | 3.0M | 2.1M | 18.6M | 10.7M | 12.4M | 13.0M | |
Long Term Debt | 6.0M | 9.3M | 13.4M | 5M | 2.5M | 3.8M | |
Net Receivables | 4.5M | 5.2M | 4.5M | 5.7M | 6.1M | 6.4M | |
Retained Earnings Total Equity | (188.8M) | (196.6M) | (221.2M) | (254.0M) | (228.6M) | (217.2M) | |
Inventory | 2.1M | 2.7M | 4.8M | 3.5M | 3.7M | 1.9M | |
Short Term Debt | 2.1M | 447K | 571K | 109K | 2.9M | 3.0M | |
Net Tangible Assets | 56.6K | 79.2M | 62.6M | 35.4M | 40.7M | 23.3M | |
Capital Surpluse | 191.6M | 277.5M | 283.2M | 287.0M | 330.1M | 215.6M | |
Short Long Term Debt | 4M | 666.7K | 1.7M | 2.5M | 2.9M | 1.8M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytosorbents Crp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytosorbents Crp's short interest history, or implied volatility extrapolated from Cytosorbents Crp options trading.
Pair Trading with Cytosorbents Crp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.Moving against Cytosorbents Stock
0.69 | BSX | Boston Scientific Corp | PairCorr |
0.65 | EHC | Encompass Health Corp | PairCorr |
0.62 | INSP | Inspire Medical Systems Earnings Call This Week | PairCorr |
0.42 | GKOS | Glaukos Corp | PairCorr |
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Cytosorbents Stock analysis
When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 0.814 | Quarterly Revenue Growth (0.08) | Return On Assets (0.32) | Return On Equity (0.97) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.